Study of Hydrocolloid Dressings Versus Antibiotic Ointment for Healing After Oculofacial Plastic Surgery

What this Trial Is About

Researchers are evaluating the use of a hydrocolloid dressing called DuoDERM EXTRA THIN for wound healing in patients undergoing oculofacial plastic and reconstructive surgery, including Mohs micrographic surgery. The study aims to compare this dressing with the current standard care involving antibiotic ophthalmic ointment to see if it can reduce the need for ointment application and lessen the burden of post-operative care. This is a randomized interventional trial without masking. At the end of the surgical procedure, participants will receive either the hydrocolloid wound dressing applied once to the sutured periocular wounds or the standard topical antibiotic ophthalmic ointment. The dressing is intended to be left in place until it is removed at a one-week post-operative visit. These two approaches represent the experimental and control groups of the study. Participants will be followed up in an office setting at 1 week, 6 weeks, and 3 months after surgery. Researchers will assess wound healing outcomes, including the number of participants experiencing wound opening dehiscence at 3 months. They will also use the Patient and Observer Scar Assessment Scale at 3 months to evaluate scar appearance. The study will monitor safety and effectiveness during these visits, with total participation lasting about three months.

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing